Report / U.S.
Published by NOISE
FDA weighs public health adviser and cancer-care CEO for leadership roles
From Evening NOISE.
The Trump administration is considering HHS senior adviser Sara Brenner and Jeff Vacirca, CEO of New York Cancer & Blood Specialists, for leadership roles at the FDA, Bloomberg reported; no final decisions have been made. The agency’s next leaders will face efforts to speed clinical trials and overhaul reviews of rare-disease drugs. The search follows the withdrawal of Heidi Overton’s commissioner nomination, while several top jobs are vacant and acting FDA leader Kyle Diamantas is expected to leave by year-end.
Saved versions
These dates record changes to NOISE’s copy. They are not event dates.